Month: April 2025

Vancouver, British Columbia, April 24, 2025 (GLOBE NEWSWIRE) — NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased to announce that it has discovered further significant oxide gold-antimony (“Antimony”, “Sb”) drill results at its Limousine Butte Project (the “Project”, “Limo Butte”) in Nevada. The Company continues to unlock the substantial gold-antimony potential of the Project, highlighting its promising prospects for further exploration and development in Nevada, one of the world’s prolific mining jurisdictions.Key HighlightsFurther positive, near-surface, oxide gold-antimony historical drillholes at Resurrection Ridge include: LB023: 2.11 g/t AuEq* over 67.1 meters (1.30 g/t Au and 0.18% Sb), including 4.29 g/t AuEq* over 30.5 meters (2.79 g/t Au and 0.33% Sb), and also including...

PITTSBURGH, April 24, 2025 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) announced today that the Company will be presenting on multiple programs in the lung, eye, and skin at upcoming scientific conferences being held in May and June. Presentation details are outlined below. American Society of Gene & Cell Therapy (ASGCT) 28th Annual MeetingInvited Oral PresentationTitle: HSV-1 as a vector system for targeting respiratory tissues in genetic pulmonary disease Presenter: Trevor Parry, PhD Date and Time: May 17, 2025 at 8:50AM CT2025 American Society of Clinical Oncology (ASCO) Annual MeetingPoster PresentationTitle: Inhaled KB707, a novel HSV-based immunotherapy, as a monotherapy in patients with advanced solid tumor malignancies affecting the lungs: Efficacy and safety results from a phase 1/2...

SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies, today announced that it will report its first quarter 2025 financial results and operational highlights after the close of the U.S. financial markets on Thursday, May 8, 2025. The Company will host a conference call and webcast at 5:00 PM Eastern Time to discuss the results and provide an update on business operations. Conference Call Dial-In & Webcast InformationDate: Thursday, May 8, 2025Time: 5:00 PM Eastern TimeUnited States: 1-800-717-1738International: 1-646-307-1865Conference ID: 90743Webcast: Link   About Cidara TherapeuticsCidara Therapeutics is using its proprietary Cloudbreak® platform...

SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) — BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today announced preclinical poster presentations at the upcoming 2025 American Association for Cancer Research (AACR) to be held at the McCormick Place Convention Center in Chicago, IL from April 25–30, 2025. Two abstracts accepted for poster presentation highlight Company’s proprietary Conditionally Active Biologic (CAB) technology Differentiated preclinical activity for CAB anti-Nectin4-antibody drug conjugate (ADC) with superior efficacy to enfortumab vedotin analogue in lung, breast, pancreatic and urothelial patient derived cancer models CAB technology provides a new generation of...

Juve Stabia’s squad value has risen 36.9%, from €11.78M to €16.13M, as the team climbs to 5th in Serie BJuve Stabia’s squad value has risen 36.9%, from €11.78M to €16.13M, as the team climbs to 5th in Serie BJuve Stabia’s squad value has risen 36.9%, from €11.78M to €16.13M, as the team climbs to 5th in Serie B Dublin, Ireland and Milan, Italy, April 24, 2025 (GLOBE NEWSWIRE) — Brera Holdings PLC (“Brera Holdings” or the “Company”) (Nasdaq: BREA), an Ireland-based international holding company focused on expanding its global portfolio of men’s and women’s sports clubs through a multi-club ownership (“MCO”) strategy, is proud to announce that S.S. Juve Stabia S.r.l., “The Second Team of Naples” and a Brera Holdings portfolio club (“Juve Stabia”), has recorded the highest market value increase in Italy’s Serie B over the...

Norovirus GII.17 variants have overtaken GII.4 as the most prevalent strain and significantly increased norovirus outbreaks in the U.S. and European countries in 2024-2025 Cocrystal Pharma’s pan-viral protease inhibitor CDI-988 shows superior broad-spectrum antiviral activity against major norovirus variants including GII.4 and GII.17 strains Company reported favorable safety and tolerability of CDI-988 in Phase 1 and plans to initiate a human challenge study in 2025 for the treatment and prevention of norovirus infectionBOTHELL, Wash., April 24, 2025 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that its investigative drug candidate CDI-988 was shown to bind to the highly conserved region of the GII.17 protease with excellent potency, similar to that shown across a range of...

CAMBRIDGE, Mass., April 24, 2025 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that its first quarter 2025 financial results will be released on Thursday, May 1, 2025, before the U.S. financial markets open. Management will host a conference call and webcast at 8:00 a.m. ET to discuss the results and provide an update on recent corporate developments. Individuals may register for the conference call by clicking the link here. Once registered, participants will receive dial-in details and unique PIN which will allow them to access the call. An audio webcast will be accessible through the Investor Relations section of the company’s...

ORLANDO, FL, April 24, 2025 (GLOBE NEWSWIRE) — Coda Octopus Group, Inc. (“CODA” or the “Company”) (Nasdaq: CODA), a global market leader in 4D/5D/6D imaging sonar technology and new generation diving technology (DAVD) for real time subsea intelligence, today reported that its UK, Portland based Defense Engineering Services Business, Coda Octopus Martech Limited, recently received an order from one of its established long term customers, a leading and longstanding UK Defense Contractor, for sub-components which will form part of a suite of autonomous mine sweeping systems. Annmarie Gayle, CODA’s Chairman and CEO, commented: “We are very pleased to see contracts relating to European Defense Programs being fast tracked and contracting barriers being removed to expedite Defense Programs. Since 1988, Martech has been a well-established...

PRINCETON JUNCTION, N.J., April 24, 2025 (GLOBE NEWSWIRE) — MISTRAS Group, Inc. (NYSE: MG), the leading global provider of integrated, technology-enabled asset protection solutions, today announced the launch of MISTRAS Data Solutions, a unified brand that consolidates the company’s data-centric services, software solutions, and technology under one umbrella. MISTRAS Data Solutions brings together a powerful suite of capabilities and brands, including: PCMS®, New Century Software, Integrity Plus, Onstream, MISTRAS OneSuite®, Sensoria®, CALIPERAY®, VPAC®II, and Triple 5. This strategic unification accelerates MISTRAS’ evolution into the first data-driven asset integrity provider, integrating advanced analytics, industrial IoT, and inspection data software and management systems to support the full lifecycle of asset protection—from...

COOTAMUNDRA, Australia, April 24, 2025 (GLOBE NEWSWIRE) — Australian Oilseeds Holdings Limited, a manufacturer and seller of sustainable edible oils to customers globally, today issued a letter to shareholders from Gary Seaton, Chairman and Chief Executive Officer, that highlights recent performance and future milestones. Dear Fellow Shareholders, Across the globe, 2024 presented serious challenges including the ongoing war in Ukraine and serious conflicts in the Middle East and growing geopolitical discord, notably with China. Our hearts go out to those whose lives are profoundly affected by these events. Despite the unsettling geopolitical discord, we are pleased with our progress since launching the Company, as a Nasdaq listed company, and its unique products of Non-GMO cold-pressed and chemically-free processed oils. Within...